title: Chromatin deregulation in disease.
abstract: The regulation of chromatin by epigenetic mechanisms plays a central role in gene expression and is essential for development and maintenance of cell identity and function. Aberrant chromatin regulation is observed in many diseases where it leads to defects in epigenetic gene regulation resulting in pathological gene expression programmes. These defects are caused by inherited or acquired mutations in genes encoding enzymes that deposit or remove DNA and histone modifications and that shape chromatin architecture. Chromatin deregulation often results in neurodevelopmental disorders and intellectual disabilities, frequently linked to physical and developmental abnormalities, but can also cause neurodegenerative diseases, immunodeficiency, or muscle wasting syndromes. Epigenetic diseases can either be of monogenic origin or manifest themselves as complex multifactorial diseases such as in congenital heart disease, autism spectrum disorders, or cancer in which mutations in chromatin regulators are contributing factors. The environment directly influences the epigenome and can induce changes that cause or predispose to diseases through risk factors such as stress, malnutrition or exposure to harmful chemicals. The plasticity of chromatin regulation makes targeting the enzymatic machinery an attractive strategy for therapeutic intervention and an increasing number of small molecule inhibitors against a variety of epigenetic regulators are in clinical use or under development. In this review, we will give an overview of the molecular lesions that underlie epigenetic diseases, and we will discuss the impact of the environment and prospects for epigenetic therapies.
authors.affiliation: Chromatin Biochemistry Group, MRC Clinical Sciences Centre, Imperial College London, Du Cane Road, London, W12 0NN, UK.
authors.forename: Anne C
authors.initials: AC
authors.lastname: Mirabella
authors.affiliation: Chromatin Biochemistry Group, MRC Clinical Sciences Centre, Imperial College London, Du Cane Road, London, W12 0NN, UK.
authors.forename: Benjamin M
authors.initials: BM
authors.lastname: Foster
authors.affiliation: Chromatin Biochemistry Group, MRC Clinical Sciences Centre, Imperial College London, Du Cane Road, London, W12 0NN, UK. till.bartke@csc.mrc.ac.uk.
authors.forename: Till
authors.initials: T
authors.lastname: Bartke
mesh_terms: D000818:Animals; D000067877:Autism Spectrum Disorder / Q000235:genetics; D002843:Chromatin / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics; D042002:Chromatin Assembly and Disassembly; D004247:DNA / Q000378:metabolism; D004785:Environmental Pollutants / Q000494:pharmacology; D044127:Epigenesis, Genetic; D005260:Female; D020022:Genetic Predisposition to Disease; D006331:Heart Diseases / Q000235:genetics; D006657:Histones / Q000378:metabolism; D006801:Humans; D008297:Male; D009154:Mutation; D009369:Neoplasms / Q000235:genetics; D019636:Neurodegenerative Diseases / Q000235:genetics
chemical_list: D002843:Chromatin; D004785:Environmental Pollutants; D006657:Histones; D004247:DNA
keywords: Chromatin; Chromatin remodeling; DNA methylation; Epigenetics; Gene expression; Histone modifications